Massachusetts Eye and Ear Infirmary Named Agilent Certified Service Provider | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies today named the Massachusetts Eye and Ear Infirmary as a certified service provider of the company's next-generation sequencing target enrichment and microarray-based comparative genomic hybridization solutions.

MEEI is an affiliate of Harvard Medical School and home to the school's Department of Opthalmology Ocular Genomics Institute. Using genomics and gene therapy, the institute is working to advance knowledge and treatment of blinding eye diseases, Agilent said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.